SCHEMBL1709267

SCHEMBL1709267

O=CC1CC12CCN(c1ccccc1)CC2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 3/20 0.44
CYP2D6 P10635 1/20 0.44
HRH3 Q9Y5N1 2/20 0.43
CYP2C9 P11712 3/20 0.43
SCN9A Q15858 4/20 0.42
ALDH1A1 P00352 4/20 0.42
CYP3A4 P08684 3/20 0.42
CYP2C19 P33261 3/20 0.42
CYP1A2 P05177 1/20 0.42
PTPRA P18433 1/20 0.40
MAPK1 P28482 2/20 0.40
LMNA P02545 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
TP53 P04637 1/20 0.39
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HTR3E A5X5Y0 1/20 0.39
HTR3B O95264 1/20 0.39
ADRB1 P08588 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1286796 0.75 USP2 (0.49) USP2CYP2D6HRH3CYP2C9SCN9A
SCHEMBL1286820 0.73 HRH3 (0.59) USP2CYP2D6HRH3CYP2C9SCN9A
SCHEMBL22657483 0.70 USP2 (0.47) USP2CYP2D6CYP2C9ALDH1A1CYP3A4
SCHEMBL29447902 0.70 USP2 (0.50) USP2CYP2D6CYP2C9ALDH1A1CYP3A4
SCHEMBL1443382 0.69 MBTD1 (0.52) USP2ALDH1A1CYP3A4MAPK1LMNA
SCHEMBL28490686 0.69 SMN1; SMN2 (0.55) CYP2D6CYP2C9ALDH1A1CYP2C19MEN1
SCHEMBL23068913 0.68 NAMPT (0.38)
SCHEMBL1709241 0.68 SCN9A (0.54) USP2CYP2D6HRH3CYP2C9SCN9A
SCHEMBL1709269 0.68 USP2 (0.74) USP2CYP2D6CYP2C9ALDH1A1CYP3A4
SCHEMBL4052281 0.66 AKR1C3 (0.52) USP2CYP2C9ALDH1A1CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012047703-A2 CYCLOPROPYL-SPIRO-PIPERIDINES USEFUL AS SODIUM CHANNEL BLOCKERS SCHERING CORPORATION (US) 2012-04-12 WO disclosed